エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/08/16 | 3,630 | 3,640 | 3,615 | 3,635 | +5 | +0.1% | 782,900 |
| 2012/08/15 | 3,630 | 3,635 | 3,600 | 3,630 | +15 | +0.4% | 697,100 |
| 2012/08/14 | 3,570 | 3,625 | 3,565 | 3,615 | +45 | +1.3% | 1,105,900 |
| 2012/08/13 | 3,550 | 3,570 | 3,545 | 3,570 | +25 | +0.7% | 455,600 |
| 2012/08/10 | 3,555 | 3,570 | 3,535 | 3,545 | -50 | -1.4% | 1,123,500 |
| 2012/08/09 | 3,545 | 3,595 | 3,530 | 3,595 | +55 | +1.6% | 1,705,900 |
| 2012/08/08 | 3,500 | 3,550 | 3,495 | 3,540 | +55 | +1.6% | 1,522,000 |
| 2012/08/07 | 3,470 | 3,490 | 3,460 | 3,485 | +5 | +0.1% | 855,000 |
| 2012/08/06 | 3,440 | 3,480 | 3,430 | 3,480 | +65 | +1.9% | 1,023,900 |
| 2012/08/03 | 3,440 | 3,465 | 3,410 | 3,415 | -45 | -1.3% | 939,900 |
| 2012/08/02 | 3,480 | 3,500 | 3,460 | 3,460 | -45 | -1.3% | 915,300 |
| 2012/08/01 | 3,460 | 3,510 | 3,450 | 3,505 | +35 | +1% | 1,011,900 |
| 2012/07/31 | 3,470 | 3,480 | 3,445 | 3,470 | +5 | +0.1% | 1,205,600 |
| 2012/07/30 | 3,430 | 3,470 | 3,410 | 3,465 | +65 | +1.9% | 800,400 |
| 2012/07/27 | 3,420 | 3,425 | 3,390 | 3,400 | -25 | -0.7% | 755,000 |
| 2012/07/26 | 3,445 | 3,445 | 3,385 | 3,425 | ±0 | ±0% | 1,099,100 |
| 2012/07/25 | 3,405 | 3,475 | 3,400 | 3,425 | ±0 | ±0% | 1,060,600 |
| 2012/07/24 | 3,420 | 3,450 | 3,420 | 3,425 | -10 | -0.3% | 763,000 |
| 2012/07/23 | 3,420 | 3,475 | 3,415 | 3,435 | ±0 | ±0% | 795,000 |
| 2012/07/20 | 3,480 | 3,480 | 3,435 | 3,435 | -50 | -1.4% | 885,500 |
| 2012/07/19 | 3,500 | 3,510 | 3,475 | 3,485 | -20 | -0.6% | 977,400 |
| 2012/07/18 | 3,495 | 3,525 | 3,490 | 3,505 | +15 | +0.4% | 1,069,100 |
| 2012/07/17 | 3,480 | 3,500 | 3,460 | 3,490 | +35 | +1% | 934,600 |
| 2012/07/13 | 3,410 | 3,475 | 3,405 | 3,455 | +45 | +1.3% | 1,383,100 |
| 2012/07/12 | 3,410 | 3,455 | 3,390 | 3,410 | -20 | -0.6% | 1,564,000 |
| 2012/07/11 | 3,415 | 3,430 | 3,410 | 3,430 | -45 | -1.3% | 1,143,700 |
| 2012/07/10 | 3,510 | 3,510 | 3,395 | 3,475 | -35 | -1% | 1,855,800 |
| 2012/07/09 | 3,450 | 3,525 | 3,445 | 3,510 | +45 | +1.3% | 1,093,700 |
| 2012/07/06 | 3,485 | 3,500 | 3,430 | 3,465 | -35 | -1% | 1,053,400 |
| 2012/07/05 | 3,510 | 3,525 | 3,490 | 3,500 | -30 | -0.8% | 1,002,900 |
| 2012/07/04 | 3,525 | 3,540 | 3,505 | 3,530 | +5 | +0.1% | 1,037,900 |
| 2012/07/03 | 3,455 | 3,530 | 3,455 | 3,525 | +40 | +1.1% | 1,096,800 |
| 2012/07/02 | 3,490 | 3,495 | 3,450 | 3,485 | -5 | -0.1% | 930,700 |
| 2012/06/29 | 3,485 | 3,500 | 3,475 | 3,490 | +15 | +0.4% | 2,010,500 |
| 2012/06/28 | 3,500 | 3,535 | 3,435 | 3,475 | +105 | +3.1% | 2,979,200 |
| 2012/06/27 | 3,350 | 3,370 | 3,320 | 3,370 | +30 | +0.9% | 1,131,700 |
| 2012/06/26 | 3,330 | 3,360 | 3,320 | 3,340 | +10 | +0.3% | 1,360,000 |
| 2012/06/25 | 3,335 | 3,355 | 3,320 | 3,330 | -10 | -0.3% | 1,307,600 |
| 2012/06/22 | 3,335 | 3,350 | 3,315 | 3,340 | -10 | -0.3% | 1,109,300 |
| 2012/06/21 | 3,330 | 3,350 | 3,325 | 3,350 | +15 | +0.4% | 1,217,600 |
| 2012/06/20 | 3,300 | 3,350 | 3,295 | 3,335 | +40 | +1.2% | 1,214,500 |
| 2012/06/19 | 3,290 | 3,310 | 3,280 | 3,295 | +15 | +0.5% | 986,100 |
| 2012/06/18 | 3,285 | 3,295 | 3,270 | 3,280 | +5 | +0.2% | 789,400 |
| 2012/06/15 | 3,285 | 3,295 | 3,270 | 3,275 | -5 | -0.2% | 857,300 |
| 2012/06/14 | 3,240 | 3,285 | 3,240 | 3,280 | +30 | +0.9% | 1,360,500 |
| 2012/06/13 | 3,230 | 3,260 | 3,225 | 3,250 | +25 | +0.8% | 912,700 |
| 2012/06/12 | 3,215 | 3,240 | 3,205 | 3,225 | -30 | -0.9% | 978,700 |
| 2012/06/11 | 3,265 | 3,275 | 3,250 | 3,255 | +15 | +0.5% | 849,000 |
| 2012/06/08 | 3,195 | 3,245 | 3,190 | 3,240 | +50 | +1.6% | 3,610,500 |
| 2012/06/07 | 3,205 | 3,210 | 3,165 | 3,190 | -20 | -0.6% | 1,843,800 |
3001～
3050
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
